BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38219299)

  • 1. Clinical characteristics, course and prognosis of Multiple Sclerosis patients with epilepsy. A case control study: MS and epilepsy.
    Sanchez M; Marone A; Silva WH; Marrodan M; Correale J
    Mult Scler Relat Disord; 2024 Mar; 83():105422. PubMed ID: 38219299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizures in multiple sclerosis.
    Sokic DV; Stojsavljevic N; Drulovic J; Dujmovic I; Mesaros S; Ercegovac M; Peric V; Dragutinovic G; Levic Z
    Epilepsia; 2001 Jan; 42(1):72-9. PubMed ID: 11207788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis and seizures: A retrospective observational study in a multiple sclerosis autoimmunity center of excellence.
    Nurre ER; Shah A; Hansen CJ; Dowling C; Thakolwiboon S; Mao-Draayer Y; Mihaylova TG
    Seizure; 2024 Feb; 115():44-49. PubMed ID: 38183827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of epilepsy in a cohort of patients with multiple sclerosis.
    Uribe-San-Martín R; Ciampi-Díaz E; Suarez-Hernández F; Vásquez-Torres M; Godoy-Fernández J; Cárcamo-Rodríguez C
    Seizure; 2014 Jan; 23(1):81-3. PubMed ID: 24099836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortico-juxtacortical involvement increases risk of epileptic seizures in multiple sclerosis.
    Martínez-Lapiscina EH; Ayuso T; Lacruz F; Gurtubay IG; Soriano G; Otano M; Bujanda M; Bacaicoa MC
    Acta Neurol Scand; 2013 Jul; 128(1):24-31. PubMed ID: 23289848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis.
    Gasparini S; Ferlazzo E; Ascoli M; Sueri C; Cianci V; Russo C; Pisani LR; Striano P; Elia M; Beghi E; Colica C; Aguglia U;
    Neurol Sci; 2017 Mar; 38(3):399-406. PubMed ID: 28054170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center.
    Langenbruch L; Krämer J; Güler S; Möddel G; Geßner S; Melzer N; Elger CE; Wiendl H; Budde T; Meuth SG; Kovac S
    J Neurol; 2019 Jul; 266(7):1789-1795. PubMed ID: 31069528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of adults and children following a first unprovoked seizure.
    Neligan A; Adan G; Nevitt SJ; Pullen A; Sander JW; Bonnett L; Marson AG
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD013847. PubMed ID: 36688481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epileptic seizures in multiple sclerosis: prevalence, competing causes and diagnostic accuracy.
    Neuß F; von Podewils F; Wang ZI; Süße M; Zettl UK; Grothe M
    J Neurol; 2021 May; 268(5):1721-1727. PubMed ID: 33324995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizures in multiple sclerosis.
    Koch M; Uyttenboogaart M; Polman S; De Keyser J
    Epilepsia; 2008 Jun; 49(6):948-53. PubMed ID: 18336559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of persistent interictal epileptiform discharges on antiseizure medication withdrawal in patients with epilepsy in five-year remission.
    Liang X; Yu N; Zhang YF; Gu L; Di Q
    Seizure; 2022 Jan; 94():100-106. PubMed ID: 34883461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When to start drug treatment for childhood epilepsy: the clinical-epidemiological evidence.
    Arts WF; Geerts AT
    Eur J Paediatr Neurol; 2009 Mar; 13(2):93-101. PubMed ID: 18567515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of epilepsy in multiple sclerosis.
    Dagiasi I; Vall V; Kumlien E; Burman J; Zelano J
    Seizure; 2018 May; 58():47-51. PubMed ID: 29656097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends of epilepsy in multiple sclerosis.
    Mahamud Z; Burman J; Zelano J
    Acta Neurol Scand; 2022 Nov; 146(5):492-498. PubMed ID: 35852006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy as a predictor of disease progression in multiple sclerosis.
    Grothe M; Ellenberger D; von Podewils F; Stahmann A; Rommer PS; Zettl UK
    Mult Scler; 2022 May; 28(6):942-949. PubMed ID: 34595974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for epilepsy.
    West S; Nevitt SJ; Cotton J; Gandhi S; Weston J; Sudan A; Ramirez R; Newton R
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010541. PubMed ID: 31237346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology-specific response to antiseizure medication in focal epilepsy.
    Doerrfuss JI; Kowski AB; Holtkamp M
    Epilepsia; 2021 Sep; 62(9):2133-2141. PubMed ID: 34328218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of epileptic seizures in multiple sclerosis varies according to time of occurrence and etiology.
    Selton M; Mathey G; Soudant M; Manceau P; Anxionnat R; Debouverie M; Jonas J
    Eur J Neurol; 2022 Dec; 29(12):3537-3546. PubMed ID: 36083790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epileptic seizures in multiple sclerosis: clinical and EEG correlations.
    Striano P; Orefice G; Brescia Morra V; Boccella P; Sarappa C; Lanzillo R; Vacca G; Striano S
    Neurol Sci; 2003 Dec; 24(5):322-8. PubMed ID: 14716527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective observational longitudinal study of new-onset seizures and newly diagnosed epilepsy in dogs.
    Fredsø N; Toft N; Sabers A; Berendt M
    BMC Vet Res; 2017 Feb; 13(1):54. PubMed ID: 28209153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.